FindTrial
Sign In

Developing tools for early detection and understanding mechanism of action of Ayurvedic drugs on Breast Cancer

Development for early diagnosis of cancer and assessment of Ayurvedic drug response in cancer â?? An exploratory study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/030893
Enrollment
40
Registered
2021-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Standard Ayurvedic Treatment for Breast Cancer: Any form of Ayurvedic treatment that the patient is undergoing Control Intervention1: Drugless: No drugs will be administered as the subj

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Informed consent 2. Age between 30 â?? 70 years 3. Confirmed diagnosis of breast cancer.

Exclusion criteria

Exclusion criteria: Diagnosis of other malignancies within 5 years prior to saliva collection Other co-morbid conditions like DM, Hypertension etc. Critical / terminally ill patients

Design outcomes

Primary

MeasureTime frame
1.Set up and establish research for early diagnosis for breast cancer. 2.Identifying novel biomarkers for cancer diagnosis. 3.Establishment of ayurvedic drug response on cancer patients.Timepoint: 56 days—

Secondary

MeasureTime frame
1. Some ayurvedic drugs will be identified with scientific validation and for future drug discovery stages. 2. Trained manpower for future research for intervention for other cancer types.Timepoint: After 2 years—

Countries

India

Contacts

Public ContactPramod Yadav

All India Institute of Ayurveda

drpramod88@gmail.com9990030755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026